Menzies Institute for Medical Research, University of Tasmania, Liverpool St, Hobart, Australia, 7000.
Menzies Institute for Medical Research, University of Tasmania, Liverpool St, Hobart, Australia, 7000.
Mult Scler Relat Disord. 2022 Jul;63:103839. doi: 10.1016/j.msard.2022.103839. Epub 2022 Apr 30.
Multiple sclerosis (MS) is a complex disease, and its pathophysiology impacts the function of immune and central nervous system cell types. Despite extensive investigation into the aetiology of MS, the underlying cause/s remain elusive and consequently, faithful in vitro or in vivo preclinical models of MS do not exist. Advances in human stem cell technologies have enabled the generation of induced pluripotent stem cells (iPSCs) from people with MS. This review summarises the discoveries made using iPSCs derived from people with MS and explores their current and potential application/s in MS research.
多发性硬化症(MS)是一种复杂的疾病,其病理生理学影响免疫和中枢神经系统细胞类型的功能。尽管对 MS 的病因学进行了广泛的研究,但潜在的原因仍不清楚,因此,不存在忠实的 MS 体外或体内临床前模型。人类干细胞技术的进步使得能够从 MS 患者中生成诱导多能干细胞(iPSCs)。本综述总结了使用来自 MS 患者的 iPSCs 所取得的发现,并探讨了它们在 MS 研究中的当前和潜在应用。